NASDAQ · DMAAU
Drugs Made In America Acquisition Corp. Units
Financial Services · Financial - Conglomerates
$11.15
Up+$0.14 (+1.27%)
Updated Nov 8, 2026, 7:05 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 247.19M
- P/E ratio
- 41.6
- Dividend yield
- 0.00%
- 52-week range
- $10.00 – $12.50
- Volume
- 203
- Avg. volume
- 3.17K
Price performance · DMAAU
DMAAU price history
1M range · 6 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
DMAAU closed at $11.15 after 6 trading sessions, down 1.33% for the selected period.
- Last close
- $11.15
- Period change
- -1.33%
- Period low
- $11.00
- Period high
- $11.30
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $11.15 | $11.15 | $11.15 | $11.15 | 203 |
| Oct 27, 2026 | $11.00 | $11.00 | $11.00 | $11.00 | 209 |
| Oct 26, 2026 | $11.01 | $11.01 | $11.01 | $11.01 | 2.61K |
| Oct 22, 2026 | $11.11 | $11.11 | $11.11 | $11.11 | 141 |
| Oct 20, 2026 | $11.22 | $11.22 | $11.12 | $11.12 | 310.27 |
| Oct 16, 2026 | $10.99 | $11.50 | $10.99 | $11.30 | 1.65K |
Latest DMAAU news
The latest Smart Investors Daily articles mentioning DMAAU.
Stock researchCompany · Overview
Company
Market Activity
Research & News
DMAAU research
Overview
Company profile and research snapshot.
Company profile
Drugs Made In America Acquisition Corp is a blank check company.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
